| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  VistaCare Medical For a good wound bed preparation VistaCare Medical develops, manufactures and distributes medical devices for the treatment of complex wounds, whether acute or chronic. We aim to contribute with health professionals to improve the lives of patients suffering from complex wounds that are difficult to treat with standard therapies. Our current product on the market VistaCare One is showing an improvement in the debridement and vascularization steps of wound healing process making it an ideal wound bed preparation companion product for grafting. The company is developing an Homecare version - VistaCare Nomad - which will bring an expert device for … Type: | 3 | 3 | 1 | 3 |
 | TargEDys From Probiotics to PreciBiomics TargEDys is a French commercial-stage biotech company specialized in the development of precision probiotics, or PreciBiomic solutions. Our mission is to detect, transpose and make available microbiome-based innovations to answer global public health challenges. How? By translating microbiome fundamental research from prestigious French institutes such as the Inserm and IGFL to applied research in probiotics, understanding the molecular mechanism of action of our strains, and developing industrial processes and IP to propose turnkey science-backed probiotics. Our vision is to bring the microbiome to the heart of healthcare and harvest its immense potential to improve the quality … Type: | 6 | 1 | 4 | 8 |
 | ALPIONER Therapeutics Building a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens. Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR). Type: | 18 | 4 | 1 | 3 |
 |  BIOPHTA Changing the lives of patients suffering from chronic eye diseases ! World Health Organization evaluates between 200 and 300 million, the number of people who are visually impaired by diseases against which pharmaceutical treatments are however existing. Many of these conditions have in common to cause permanent vision loss if they are not treated consistently. The lack of adherence to prescription eye drops is the #1 Unmet Medical need in Ophthalmology. Poor treatment Compliance and Adhesion leads to a worse progression of Eye Diseases. BIOPHTA wants to change the lives of patients suffering from chronic eye diseases by creating a … Type: | 6 | 4 | 3 | 7 |
 | Atoxigen ATOXIGEN is your partner in early R&D. We offer a variety of standardized or customized assays based on the latest innovations in the fields of cellular biology, molecular biology and genomics. Innovative predictive efficacy assays on reconstructed epidermis or primary cell lines from human explants (proteasome, autophagy, detoxification, anti-ageing...); in vitro genotoxicity testing (micronucleus and chromosome aberration tests); endocrine disruptor screening; customized services. Biotechnologies, Testing & Research, Evaluation toxicologique, and Assurance qualité Type: | 2 | 0 | 2 | 3 |
 | MAD-UP Rehabilitation, Physiotherapy, Sports, New technologies, Seniors. Functional rehabilitation without the time constraints and risks of intense effort. MAD-UP Pro is a fast and individualized rehabilitation and muscle strengthening solution. Health professionals can rely on an innovative tool, the only one capable of regulating the pressure applied to a muscle during exercise. By adapting the blood flow restriction training process (BFR Training), MAD-UP Pro secures a practice already scientifically recognized and medically validated. BFR by MAD-UP introduces a new therapeutic practice and improves patient progress. Whatever the pathologies, the device assists physiotherapists in an optimal and safe way. In order to … Type: | 7 | 1 | 3 | 11 |
 | Continuum Plus Santé [Automatic translation follows] Reinventing the monitoring of patients under anticancer drugs #AKOadom, Continuum+ Connect Telemonitoring Platform Closer to patients. cancer, health, digital, E-health, Home support, and telemonitoring Type: | 39 | 8 | 34 | 19 |
 | Apmonia Therapeutics Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1). Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1. immunologie and oncologie Type: | 28 | 12 | 20 | 18 |
 | ImCheck Therapeutics Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune … Tags: FrenchTech120 FrenchTech2030 Type: | 32 | 15 | 22 | 56 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 15 | 5 | 11 | 68 |
 |  Alzohis Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat Type: | 3 | 2 | 1 | 2 |
 | StemInov Births can save lives StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology Type: | 15 | 10 | 3 | 4 |
 | E>Swin [Automatic translation follows] E-Swin is a French company founded and managed by Yves Vincent BROTTIER that designs, manufactures and markets high-tech light products, all of which are medically certified. In 2007, E>Swin developed and marketed the E>One, the first professional personal epilator with a flash lamp. This high-tech device allows individuals to access a patented technology that was previously reserved for beauty and health professionals. Our research laboratory and production unit based in Yvelines allow us to innovate by working on other applications of pulsed light: dermatology (acne, pigment spots), aesthetics (anti-aging) and medical (ophthalmology). The E>Eye is the only … Type: | 0 | 0 | 0 | 23 |
 | Naobios Biomanufacturing services Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches. Type: | 6 | 1 | 6 | 32 |
 | Ludocare Evidence-based digital therapies that improve adherence and overall health of children with chronic conditions. Created in 2017 in Lyon, Ludocare develops evidence-based digital therapies for the benefit of patients, those around them and healthcare professionals. ✅ Its objective: better control of the disease and stabilization of basic treatment, to improve the quality of life of children with chronic illnesses. 💡The medical purpose of JOE digital therapy is to improve asthma control through better use of inhalation devices and increased compliance with drug treatments, and thus preventively reduce attacks and exacerbations. ➡️ To date, Ludocare is part of a scientific approach … Type: | 25 | 8 | 22 | 9 |
 | HMT [Automatic translation follows] Work different - Work differently HMT supports all organizations of all sizes in their prevention approach to improve working conditions and limit the risks of occupational diseases (MSDs, RPS, etc.). Based on an ergonomic approach, our multidisciplinary team helps you identify, propose and integrate technical and organizational solutions that meet your projects. Our design office can also co-design and manufacture, in Tarbes, technical solutions specific to your activities. Mechanics, IT, Electronics, Handling, Exoskeleton, Design, Production, Study, and Ergonomics Type: | 23 | 0 | 23 | 47 |
 | Vaxxel The future of vaccines against respiratory infections. Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel. recherche-développement, biotechnologies, santé, and vaccin Type: | 7 | 0 | 6 | 11 |
 | ABC transfer Ultraclean Sterile Transfer Solutions For The Global Pharmaceutical Industry ABC Transfer is an industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the pharmaceutical industry. It provides the ultimate sterile and particle-free environment for safe drug manufacturing and bioprocessing; ensuring GMP compliance, ultra-cleanliness and enhanced ergonomic safety. Its system consists of future-proof alpha doors, beta containers, single-use bags and other superior quality sterile processing accessories based on 12 patented designs. The ABC Transfer system is the first to satisfy 50 improvement criteria resolving customers’ challenges worldwide. Led by an executive team of pharma transfer solution experts with decades … Type: | 0 | 0 | 0 | 14 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 1 | 1 | 0 | 15 |
 | Poietis Make tissues real Poietis (gr. Ποίησις: to make). "The one who makes things real." Poietis is a health-tech company specialized in the development of solutions for manufacturing human tissues by 4D Bioprinting. Poietis commercializes its Next Generation Bioprinting (NGB) systems for Cell Therapy & Research Centers and also develops advanced therapies with leading clinicians. 4D Bioprinting, Tissue engineering, Laser, bioprinting, skin, and cell therapy Type: | 31 | 21 | 7 | 23 |
 | Regulaxis SAS Regenerative Medicine - Growth Disregulation - Oncology REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its … Type: | 0 | 0 | 0 | 3 |
 | Selenium Medical Intuitive Innovation for Infection Prevention We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box thanks to our specialization and expertise in the medical industry. We can offer you our know-how, specific skills and expertise in technical consultancy for your projects in clean room injection, surface treatment and sterile packaging of your medical devices, through our different divisions SELENIUM Injection, SELENIUM Surface Treatment and SELENIUM Packaging. In all our divisions, … Type: | 12 | 1 | 10 | 46 |
 | X'PROCHEM We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences Type: | 1 | 0 | 1 | 13 |
 | BoneTag Reinventing orthopedics BoneTag is a french start-up, based in Montpellier, which is focused on the development of innovative medical devices in orthopedics. BoneTag is developing two medical devices: • INCESSU: A solution making total knee arthroplasties (TKA) smart and connected. This medical device allows the communication between the implanted TKA and the surgeon. The communicated data are: identification information about the TKA, temperature in contact with the bone and motion between the TKA and the bones. • KNEEMATICS: A dynamic 3D representation of the kinematics of total knee arthoplasties. This device allows the visualization in real-time, and in 3D, of … Type: | 1 | 1 | 0 | 6 |
 | Vibiosphen From Microbes to One Health. Taylor made R&D to tackle infectious diseases. Vibiosphen is a SME healthcare biotechnology in infectious diseases founded in 2014. Given the important and interdependent human, animal, and environmental dimensions of antimicrobial resistance, the One Health concept promotes a global effort to achieve the best health for people, animals, and the environment. In this context, Vibiosphen takes part of the efforts that are underway to develop new anti-infective therapies, to rejuvenate the antibiotic pipeline, develop novel antibiotics, and discover innovative therapeutic strategies for priority pathogens. Based on its pluridisciplinary and integrated approaches, Vibiosphen, with more than … Type: | 5 | 3 | 2 | 8 |
 | Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI) Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents … Type: | 3 | 2 | 1 | 41 |
 | Genvade Therapeutics Dedicated to developing treatments for rare diseases originated from nonsense mutations Genvade aims to harness the power of nonsense mutation readthrough molecules to develop treatments for some of the most burdensome rare diseases. Our lead compound targets indications include cystic fibrosis, Duchenne muscular dystrophy and other genetic diseases. small molecules, drug discovery and development, rare diseases, nonsense mutation corrector, cystic fibrosis, genetic diseases, oncology, readthrough, and Duchenne Type: | 2 | 2 | 0 | N/A |
 | Generare Natural molecule discovery, industrialized Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods for discovering new natural products are increasingly ineffective. Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution. This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation. genomics, synbio, and microbiology Type: | 7 | 3 | 4 | 13 |
 | MAG4HEALTH Affordable high-end neuroimaging We make and sell brain imaging systems showing neural activity called magnetoencephalographs (MEG). We democratize the use of MEG, using a space technology, to effectively detect brain defects and improve brain cares MEG, medical device, and functional imaging Type: | 5 | 4 | 3 | 18 |
 | COHESIVES LA REVOLUTION DEEPTECH DU WOUND CARE & SUTURING COHESIVES is a co-development platform for medical devices using our adhesive technology. We are based in DIJON, France. Adhesive, suture, and wound dressing Type: | 6 | 4 | 3 | 13 |
 | AbilyCare The digital solution to measure one's walk and balance Based on French research, Abilycare was developed by and for practitioners. AbilyCare is a solution that measures walk and balance in order to prevent frailty risks at any moment of our life. It's a medical device (certification in progress), easy and fast to use in order to : - detect early signs of frailty - develop preventive actions to initiate the process of reversibility - monitor the patient's state over time and measure the benefit of a rehabilitation or prevention program Type: | 14 | 6 | 10 | 6 |
 | Igyxos Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal Type: | 2 | 1 | 2 | 11 |
 | DÔMES PHARMA Cultivate our positive impact Dômes Pharma is an independent, family-owned company that has been active in the pharmaceutical industry since 1947. It employs 400 people in France, England, Germany, Spain and the USA and has a consolidated turnover of 90 million euros. For over 70 years, the Group has been developing, manufacturing and marketing solutions for the health and well-being of pets. The Dômes Pharma Group has 3 complementary areas of expertise that integrate the entire value chain of medicine and cover all distribution channels. Animal Health Type: | 21 | 9 | 14 | 131 |
 | THERAVECTYS Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective … Type: | 2 | 2 | 0 | 19 |
 | Spectrum Medical Ltd Spectrum Medical supplies Clinical Information Solutions that include Medical Device Connectivity Technologies, Electronic Medical Record Systems, Telemedicine Capabilities and Compliance and Patient Safety Solutions. Spectrum Medical also supplies Non-invasive Diagnostics Systems for extracorporeal procedures. Type: | 0 | 0 | 0 | 287 |
 | Coriolis Pharma Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large … Type: | 0 | 0 | 0 | 170 |
 | Lytix Biopharma A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel therapy to fight cancer. Lytix Biopharma is a clinical-stage immuno-oncology company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. Lead compound LTX-315 provides access to antigens by using the patient’s own tumor as source of antigens and turns cold tumors hot. Local treatment with LTX-315 targets the first step in the cancer immunity cycle with a potential cornerstone position in immunotherapy. Type: | 0 | 0 | 0 | 17 |
 | CEMA Technologies Technologies for Efficient Tooling For more than 50 years we manufacture multi-cavity molds (>128) for drug delivery devices. plastique, moule d'injection, injection mold, medical, diagnostic, pharmaceutical, design control, and metrology Type: | 6 | 1 | 3 | 32 |
 | TECH4HEALTH [Automatic translation follows] Supporting health technologies throughout their maturation cycle. A network of expertise composed of responsive platforms, which answer the "Why, When and How to carry out preclinical and clinical studies". The network aims to encourage initiatives and facilitate the realization of multidisciplinary and collaborative translational research projects in the field of the evaluation of medical devices, e-Health and biomaterials. It is a national network bringing together academic expertise in regulation and evaluation for the development of medical devices, e-Health and biomaterials throughout their life cycle. These axes may be expanded according to the needs, strategic issues and resources … Type: | 1 | 1 | 0 | 3 |
 | Bionoveo [Automatic translation follows] Health Research & Development Center BIONOVEO offers project leaders, industrial or academic, the biological, technical and methodological skills and resources necessary for the development of new therapeutic and diagnostic strategies, as well as their production processes. Type: | 3 | 1 | 3 | 4 |
 | MEDICAL EXPANSION MEDICAL EXPANSION is a consultancy specialized in supporting the international development of small to medium sized enterprises in the sector of HEALTHCARE. Whether you are in OTC, medical devices, biotech, nutritional supplements, or natural health products, we can bring you tailor-made support and solutions and will obtain tangible results to fulfil your international ambitions. We can deliver on this promise thanks to more than 18 years of experience in international development, with the support of a network of expert associates specialized in healthcare marketing. If you have the will, we have the experience and know-how. So just give us a … Type: | 1 | 1 | 0 | 4 |
 | COLTENE Micro-Mega [Automatic translation follows] 🇬🇧 French designer and manufacturer since 1905 💪 For dental professionals | 🌍 Global supplier The MICRO-MEGA company, whose original activity dates back to 1905, is recognized worldwide for the design, manufacture and marketing of medical devices intended for dental surgery. Its root canal and obturation instruments, its handpieces and contra-angles and its hygiene devices demonstrate its unique technical and scientific know-how and the impeccable quality of its endodontic products made in France. medical, dentistry, dentaire, and endodontie Type: | 9 | 1 | 4 | 86 |
 | Santélys [Automatic translation follows] Finding a solution at home, regardless of the age, level of dependency and state of health of patients. Recognized as being of public utility, Santélys is a non-profit institution specializing in health, home care and training. Coordination, prevention, education, hospitalization, care, support, technologies, telemedicine and remote monitoring, at home and in a local unit: Santélys' vocation is to find a solution at home, regardless of the age, level of dependency and state of health of the patient suffering from a chronic illness (renal failure, respiratory failure, diabetes, etc.) or cancer. Nursing training, training of nursing assistants, continuing … Type: | 4 | 2 | 3 | 468 |
 | AURAL Alsace [Automatic translation follows] Progress 🚩and innovate🚀 Cooperate and commit to humanity HISTORICAL Created in 1972 by Professor JAHN, Head of the Nephrology and Hemodialysis Department at the Strasbourg University Hospital, AURAL is a non-profit association offering all treatment modalities for chronic renal failure as well as home hospitalization and is present throughout the Alsace region. The HAD activity began in May 2004. In 1981, AURAL started Continuous Ambulatory Peritoneal Dialysis. The first assisted AD units were set up in 1985, and in 1996, the UMs. The DPA was created in 1994, and allows young patients to continue a professional activity … Type: | 2 | 2 | 0 | 145 |
 | GMED [Automatic translation follows] GMED is a French certification body and notified body in Europe (identification number 0459). GMED is a French certification body and notified body in Europe (identification number 0459). It is responsible for assessing the conformity of medical devices according to the applicable European directives (90/385/EEC, 93/42/EEC and 98/79/EC). Accredited by the French Accreditation Committee COFRAC (under certificate No. 4-0608), in accordance with the NF EN ISO/CEI 17021: 2015 standard, GMED carries out quality management system certification activities according to ISO 9001: 2015 and ISO 13485: 2016 standards. GMED is also an audit body recognized by the MDSAP … Type: | 13 | 3 | 10 | 244 |
 | HC NEXT Expert en gestion de projet de développement de produits de santé innovants HC NEXT is a consulting company expert in project management and vendor management for drug and medical device development! HC NEXT’s mission is to speed up and derisk drugs and medical devices developments to ensure that each innovation becomes a product to patient’s benefit. HC NEXT consultants are both project management specialists and generalists in the field of healthcare product development. We kindly but seriously challenge habits, routine, bias, status quo, prejudices. Dare to be different! Dispositif médical, Médicament, Gestion de Projet, Développement, CMC, Qualité, Réglementaire, COO, and … Type: | 4 | 1 | 4 | 3 |
 | MBCP® Technology (Advanced Medical Solutions) experts in bone regeneration Biomatlante is a specialist in synthetic biomaterials promoting bone regrowth and the precursor of bone substitute technologies. We market our products for orthopedic, trauma, spine, ENT, stomatological and dental surgery in more than 50 countries. Our Mission Develop and promote the proprietary MBCP® Technology as the scaffold of reference in any bone regeneration solution for best-in-class patient care. Our Vision Bone surgeries often demand grafts for which autograft is considered as the gold standard in terms of tissue regeneration performance and limited rejection risk. Autograft is available in limited quantity though, and harvesting methods are expensive … Type: | 3 | 1 | 3 | 30 |
 | HBR INNOVATION [Automatic translation follows] "If you take care of your employees, they will take care of your company" (R. Branson) Do you want to improve the working conditions of your employees? You have already identified, in your company, positions with physical constraints and where you encounter problems of Musculoskeletal Disorders (MSDs). Are you wondering if exoskeletons are the solution for your company/establishment? Do not hesitate to contact us at: e-mail: contact@hbrinnovation.fr Tel: 05 56 14 30 56 We will analyze the workstations together in order to find the most relevant solution for your organization. What is an exoskeleton? It is a … Type: | 1 | 1 | 0 | 1 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … Type: | 18 | 11 | 10 | 9 |
 | Hybrigenics Services Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins' functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict … Type: | 7 | 2 | 5 | 33 |
 | Senti Biosciences Outsmarting complex diseases with more intelligent medicines Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell … Type: | 2 | 0 | 2 | 54 |
 | Rheolution We empower Life Sciences and Agri-Food with Soft Matter AnalyticsTM At Rheolution, we design and commercialize IoT-enabled modular lab instruments for modern data-driven science. Our instruments and software empower scientists, engineers, and innovators with a suite of cutting-edge optical and mechanical testing instruments for the Life Sciences and Agri-Food. Our instruments are not only highly modular and scalable but also remarkably intuitive. What sets us apart is our pioneering IoT approach, granting our users and customers unprecedented control over expanding their testing capabilities according to their preferences and needs: - Embrace the potency of IoT-enabled modularity and the adaptability of … Type: | 2 | 1 | 1 | 25 |
 | AdalbaPro smart insect nutrition Ynsect's high-tech vertical farm and processing facility in the Netherlands produces innovative and sustainable ingredients for the food industry derived from insects under the brand name AdalbaPro. Our functional ingredients contain highly digestible proteins along with essential nutritional building blocks like vitamins, minerals, fiber and healthy fats. In our controlled and highly scalable vertical farm, Ynsect reduces your global footprint in the most effective way. High quality protein powder, Edible oils, Sustainable food ingredients, sustainable food, sustainable feed, and protein manufacturing Type: | 4 | 3 | 1 | 8 |
 | Prellis Biologics Integrating human biology with machine learning for antibody discovery Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXISTM, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in the same platform. Prellis Biologics, Inc. is a privately held company based in the San Francisco Bay Area, CA. Apply at www.prellisbio.com. Lymph Node Organoids, Immunogenicity Screening, Human Antibody Discovery, and Antibody Discovery Type: | 11 | 3 | 10 | 46 |
 | PharmaBiome AG Pioneering the development of microbiome-based therapies using proprietary tools for their design and production. PharmaBiome is a privately-held spin-off company of ETH Zurich and a pioneer in the production of live biotherapeutic products to address disturbances of the gut microbiome. It has developed the first-in-the-industry, patent-protected technology platform for the production of standardized microbiome-based products. Founded in Zurich in 2015, at the intersection of microbiology, biotechnology, and data science, PharmaBiome believes that the future of microbiome-based therapeutics lies in developing the biotechnology needed to produce a solution compatible with the safety, efficiency, and trial requirements of any human medicine. This … Type: | 1 | 0 | 0 | 11 |
 | Really Clever Buckle up. It’s time we got clever. The future's here. And it's powered by fungi. We’re a fungal discovery platform, pioneering new solutions to some of the planet’s most pressing problems. From high-quality leather-like materials to pharmaceuticals, we’re pioneering ground-breaking new products that don’t cost the Earth. Thanks to these innovative biomaterials, we can replace planet damaging products without compromising on quality. Type: | 1 | 0 | 1 | 21 |
 | EnsiliTech Creating biologicals without refrigeration. Our novel ensilication technology exploits the growth of protective silica nanoshells on the surface of vaccine components, to prevent degradation, which can lead to vaccine spoilage. Once applied, our vaccines can be stored and transported without the need for cold chain infrastructure, preventing wastage, improving shelf-life and increasing vaccine accessibility globally. Ensilication can be applied to protect a wide variety of biomolecules against environmental degradation, eliminating the need for cold chain requirements and propelling the development of more oral and mucosal delivery of vaccines and therapeutics for both animals and humans. We are actively looking for … Type: | 2 | 1 | 1 | 14 |
 | Hoxton Farms Cultivating a deliciously fatty future. Based in London, Hoxton Farms is creating a deliciously fatty future. We craft cruelty-free, sustainable fats to combine with plant protein for delicious meat alternatives. Type: | 15 | 3 | 15 | 55 |
 | Mitra bio Unlocking the secrets of skin aging with epigenetics Next Generation Skin Health Type: | 3 | 2 | 1 | 8 |
 | Orano Med Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information … Type: | 10 | 2 | 10 | 152 |
 | Neurotech International Ltd Neurotech International Ltd (ASX:NTI) is a clinical-stage biopharmaceutical company developing neurological solutions Neurotech International Limited (ASX:NTI) is a clinical-stage biopharmaceutical development company focused predominately on paediatric neurological disorders. Neurotech has completed a Phase I/II clinical trial in Autism Spectrum Disorder (ASD), which demonstrated safety and efficacy results at 28 days, 20 weeks and 32 weeks of daily treatment with NTI164. The Company commenced a Phase II/III randomised, double-blind, placebo-controlled clinical trial in ASD in Q4 CY2022. The Company will also be conducting additional Phase I/II trial in Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) and Paediatric Acute-Onset Neuropsychiatric … Type: | 2 | 0 | 3 | 8 |
 | Nature's Fynd A food company for optimists. Nature’s Fynd is a Chicago-based food company creating versatile alternative proteins to nourish the world’s growing population while nurturing the planet. Born out of research conducted for NASA on microbes in Yellowstone National Park, the company’s breakthrough technology produces FyTM. Fy is a new-to-the-world, nutritional fungi protein that only uses a fraction of the resources required by traditional agriculture. We use Fy to make delicious, nutritious, and sustainable meat and dairy alternatives. Type: | 8 | 5 | 3 | 139 |
 | mOm Incubators Providing global access to high-quality healthcare Just Imagine if there was a way to improve access to affordable high-quality neonatal care worldwide. Just Imagine if neonatal technology was designed to work across different environments, was intuitive to use, easy to set up and simple to maintain. Just imagine if no matter where you are, you have access to the technology that can help save lives mOm is on a mission to rethink how healthcare is delivered and accessed by solving problems from the ground up. We deliver simple, effective and reliable medical devices that can operate anywhere from remote & … Type: | 7 | 3 | 5 | 13 |
 | Uman Sense We have developed Stroke Alarm — a wearable aid for patients with elevated stroke risk. Our product: Stroke is the most common cause of permanent disability in adults, and the second most common cause of death in the Western world. Today, people who suffer a stroke can be cured if they receive the right treatment in time. Unfortunately, most arrive too late. We hope to change that with Stroke Alarm — a wearable aid for patients with elevated stroke risk. Do you manage patients with increased risk of suffering a stroke? Right now, we offer the Swedish healthcare the opportunity … Type: | 0 | 0 | 0 | 7 |
 | HAYA Therapeutics Inspired to Transform, The Genome Informs - RNA-Guided Therapeutics to Target Disease Causing Cell-States HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing … Type: | 3 | 2 | 0 | 51 |
 | HEDERA-22 Intelligent Natural Product Discovery Platform. Hedera-22 is dedicated to unveiling novel natural products to address critical gaps in agriculture markets. Our focus involves creating an advanced natural product discovery platform, utilizing DNA-based synthesis and exclusive predictive bioinformatics. This innovative approach streamlines discovery, enhancing output, diversity, and compound maturity. Our extensive molecule library is open for screening, inviting opportunities for licensing or partnerships. Committed to contributing to a sustainable planet, our goal is to develop environmentally friendly products for crop protection, fostering a greener and more resilient future. Next Generation Biomolecules, Predictive approaches, Synthetic biology, Bio-informatics, Natural Products Discovery, AI, and … Type: | 1 | 0 | 0 | 11 |
 | MucoLife Therapeutics We develop novel mucolytic drugs to transform the treatment landscape of COPD and other lung diseases. We develop novel mucolytic drugs to transform the treatment landscape of COPD and other lung diseases. COPD and Mucus Type: | 0 | 0 | 0 | 2 |
 | ILC Therapeutics ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy. ILC Therapeutic’s platform approach has produced two first-in-class lead candidates, AlfacyteTM and DermacyteTM focused on antiviral and dermatological indications respectively, which are progressing towards the clinic. Type: | 0 | 0 | 0 | 7 |
 | Epitopea Exploiting a new class of tumour specific antigens for cancer therapy A newly established NewCo developing therapeutics targeting a novel class of tumour-specific antigen. TCR-T cells, Immuno-oncology, Vaccines, Bi-specifics, Splicing, Epigenetics, Oncology, T cell biology, and Antigen presentation Type: | 3 | 0 | 3 | 21 |
 | Mestag Therapeutics New therapies for cancer and inflammatory disease targeting fibroblast-immune interactions Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for cancer and inflammatory diseases. Through our unique understanding of fibroblast biology, we are advancing a pipeline of first-in-class tailored antibody programs and targets for new treatments. Backed by committed leading global investors, world-class founders and a highly experienced leadership team, Mestag offers an exciting, diverse and balanced place to work, with competitive benefits, generous vacation time and the room to grow and develop your career. biotechnology, fibroblasts, oncology, immuno oncology, inflammatory disease, and datascience Type: | 0 | 0 | 0 | 54 |
 | Alesi Surgical Ltd Developing and commercialising products that improve the safety, efficiency and outcomes of advanced surgical procedures Alesi Surgical announced in 2023 that it had attained FDA clearance for its groundbreaking Ultravision2 smoke management solution. The breakthrough new Ultravision system includes the world’s first surgical tool integrating electrosurgery and class-leading surgical smoke control in a single laparoscopic device. Alesi Surgical was founded to develop and commercialise products that improve the safety, efficacy, and outcomes of surgical procedures. The company is a spin-out of the Welsh Institute for Minimal Access Therapy (WIMAT), a leading surgical training centre in the UK. Alesi Surgical has … Type: | 1 | 1 | 1 | 21 |
 | CardiaTec Biosciences Decoding cardiovascular disease biology for novel therapeutic discovery CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. We leverage large and high-dimensional human omics data to better navigate complex disease biology to discover novel and differentiated therapeutics. Type: | 5 | 2 | 2 | 10 |
 | CorFlow CorFlow is developing a system that will be the first to detect & treat microvascular obstruction (MVO) in real time. CorFlow was founded on the belief that current PCI and cardiac care remains suboptimal due the fact that underlying microvascular dysfunction and obstruction is not detected and treated adequately. CorFlow believes, like much of the medical community, that the next frontier of innovation and positive impact on clinical outcomes in cardiology and beyond will come from the microvascular space. Our first solution is a system that will be the first to diagnose microvascular obstruction (MVO) in real time during PCI … Type: | 0 | 0 | 0 | 19 |
 | MedLumics, S.L. MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life. Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth. Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality. MedLumics, Enlightening Healthcare Cardiology Type: | 0 | 0 | 0 | 25 |
 | PL BioScience GmbH Changing cell culture with animal-free cell growth promoters We at PL BioScience are experts in cell culture supplements derived from human Platelets. Our mission is to enhance the advances in cellular research and therapy with one forward-looking Technology: ELAREMTM. The ELAREMTM Platform unites tailored cell culture supplements based on Human Platelet Lysate. The human origin combined with a rich growth factor content not only supports cell growth, but also enables various applications: The products cover all needs of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from lab to patients … Type: | 0 | 0 | 0 | 25 |
 | ILYA Pharma Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients ATMP, Gene Therapy, Biologics, Drug development, Clinical trials, GMP, Growth, H2020, Uppsala, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, Cutting edge, and IBD Type: | 7 | 0 | 5 | 17 |
 | HepatoChem Reinventing Chemistry for Life Sciences HepatoChem is an emerging life sciences company dedicated to the commercialization of our unique approach for producing new chemical entities for metabolism study and drug discovery. Metabolite synthesis, Custom synthesis, photochemistry, research instrument, and photoreactor Type: | 0 | 0 | 0 | 8 |
 |  Sunogel Inc Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration. Type: | 0 | 0 | 0 | 1 |
 | ReNewFood Novel Protein-Based Flavouring Ingredients ReNewFood is an early stage venture looking to produce novel protein-based flavouring ingredients with a focus on the plant-based and alt-protein markets. Taste is central to the food experience and one of the most important drivers of food choice. At ReNewFood we're focused on making ingredients that can add new flavours and enhance or mask existing ones, all with the aim of brining great taste to our customers' products. The ReNewFood team are experts in when it comes to precision fermentation, and we're going to be harnessing this green technology to make sure our products are … Type: | 0 | 0 | 0 | 1 |
 | Translation-X Developing novel therapeutics for Autism Spectrum Disorders Translation-X is a spin-off project at the Biozentrum, University of Basel. We are developing novel pharmacological tools to reduce core symptoms of autism by targeting RNA translational machinery. Type: | 0 | 0 | 0 | N/A |
 | Molecular Partners Pioneering DARPin Therapeutics for Patients Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA. DARPins, Oncology, Immuno-Oncology, Radiopharmaceuticals, … Type: | 0 | 0 | 0 | 175 |
 | Blue Earth Therapeutics Blue Earth Therapeutics Ltd is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat patients who have cancer. With proven leadership and therapeutic radiopharmaceutical expertise, Blue Earth Therapeutics has an emerging pipeline of precision targeted therapeutic radiopharmaceuticals, initially focused on prostate cancer with plans to expand into additional disease areas in oncology. The Blue Earth Therapeutics story begins in 2021, when the company was formed in Oxford, UK as a sister company to Blue Earth Diagnostics Ltd and part of the Bracco family of companies. Bracco Imaging S.p.A. is a world‐leading diagnostic imaging … Type: | 0 | 0 | 0 | 12 |
 | Axovia Therapeutics Driving gene therapy breakthroughs to develop transformative AAV treatments for patients with ciliopathies like BBS Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families and caregivers. Axovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic and retinal dysfunctions. Type: | 0 | 0 | 0 | 6 |
 | PHSE Delivering life science 🚚✈️🚢🏥💊❤️ Founded in 1999, PHSE is today a market leader providing GDP compliant time-critical and temperature-sensitive transport solutions to the pharmaceutical, biotech and life sciences industry, serving the hospital, home care and clinical research channels. It ranks internationally among the few providers specialising exclusively in the healthcare segment and in the management of worldwide shipments by air, land and sea of pharmaceuticals, radiopharmaceuticals, biotech, clinical trials, biological samples and celle & gene therapies, at any required temperature conditions. The year 2020 marks an important step in the development of PHSE's international platform, which counts 5 acquisitions between … Type: | 0 | 0 | 0 | 185 |
 | Blue Cell Therapeutics We are dedicated to develop novel stem cell therapies to treat chronic diseases Welcome to Blue Cell Therapeutics' LinkedIn page! At Blue Cell Therapeutics, our mission is to revolutionize the treatment of erectile dysfunction applying Blue Cell therapy, for men with post-(radical) prostatectomy. We are committed to develop an 'off-the-shelf' curative allogenic stem cell therapy for erectile dysfunction with enhanced safety, efficiency, and accessibility. Our cutting-edge research translates fundamental science into practical, life-changing treatments, bridging the gap between scientific discovery and clinical application. Blue Cell Therapeutics aims to establish the golden standard treatment for erectile dysfunction using innovative stem cell … Type: | 0 | 0 | 0 | 13 |
 | Quest B2B Enabling Cultivated Meat We are Quest, a UK-based B2B company developing high quality cell lines and ingredients that will make cultivated meat affordable and sustainable. Type: | 0 | 0 | 0 | 9 |
 | AAX Biotech AB Leveraging science and innovation to accelerate the development of next-generation antibody therapeutics. AAX Biotech AB is a biotech company spun out from Karolinska Institutet by co-founders Mats AA Persson and Daniel X Johansson. We specialize in next-generation antibody therapeutics through our two unique and proprietary technologies, SeqitopeTM and Opti-mAbTM, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. Our team is made up of highly qualified experts, all with PhDs in relevant fields. Our mission is to innovate and solve unmet needs … Type: | 3 | 0 | 3 | 4 |
 | Fluicell Making tissue therapeutics possible to defeat serious disease Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable … Type: | 0 | 0 | 0 | 16 |
 | AviadoBio A revolution in gene therapy for neurodegenerative disorders. At AviadoBio, we are relentlessly chasing cures by translating groundbreaking science and precision delivery into life-changing medicines for people living with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). With our deep understanding of the brain and our suite of proprietary gene therapy platforms and delivery technologies, we are working relentlessly to overcome the challenges of delivering the right drug to the right place. Our innovative, neuroanatomy-led approach is designed to maximize the therapeutic potential of gene therapy to halt or potentially reverse neurodegenerative diseases. The Company’s technology is based on pioneering … Type: | 1 | 1 | 1 | 69 |
 | Resolution Therapeutics Pioneering Macrophage Cell Therapy for Transformative Outcomes in Inflammatory Organ Diseases Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by Syncona. Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, … Type: | 2 | 0 | 2 | 80 |
 | Dia Beta Labs Ltd Target-led management of the causes of metabolic disease Diabetes currently effects over 537 million adults worldwide, with obesity-driven Type 2 Diabetes accounting for over 90% of cases. Dia Beta Labs build on over 30 years of high-impact research from our founding research group at Ulster University to realise the potential of next-generation therapeutics for metabolic disease. It is our goal to impart significant and much-needed change in the management of the global diabetes/obesity crisis. Diabetes, Peptide Development, Metabolic Disease, Obesity, and Peptide Therapeutics Type: | 1 | 0 | 1 | 3 |
 | BIOINTAXIS Changing the paradigm in Friedreich's ataxia Biointaxis is an academic spin-off focused on the development of gene therapies for neurodegenerative disorders. Biointaxis lead product is a gene therapy product for Friedreich ataxia. Type: | 2 | 1 | 1 | 6 |
 | Shift Bioscience Simulation guided cell rejuvenation to defeat the diseases of aging Shift Bioscience is using simulation guided cell rejuvenation to defeat the diseases of aging. Cellular reprogramming with Yamanaka factors can reverse aging in the dish but is not yet safe for clinical use. Shift has pioneered the first high throughput and high accuracy aging biomarker, which has been leveraged inside AI-based cell simulations to identify safer rejuvenation gene-factors. Shift envisions the development of a single drug-family that can treat multiple diseases of aging, after which full and continued health into old age becomes the norm. longevity, reprogamming, machine learning, aging … Type: | 0 | 0 | 0 | 16 |
 | Kaminari Medical Combining ultrasound and optical imaging to revolutionize coronary revascularization PROBLEM Insufficient treatment of vulnerable plaque in the coronary arteries lead to costly and health impairing re-catheterizations In 2015, Coronary Artery Disease (CAD) affected 110 million people and resulted in 8.9 million deaths worldwide. CAD occurs when the arteries that supply the heart muscle with blood become hardened and narrowed, due to the buildup of cholesterol and plaque on their inner walls. Current treatment: To open the blocked coronary arteries, 80% of the patients are treated using a Percutaneous Coronary Intervention (PCI). - Of those patients treated with PCI, 12% get … Type: | 0 | 0 | 0 | 7 |
 | sallea Adding the third dimension to cells. The growth of cells of a living being is key for an increasing range of applications, including in-vitro drug testing and cellular agriculture. In order to closely mimic the natural environment of such cells in-vitro, highly porous structures with tuneable mechanical and permeability properties are required. Sallea is developing such scaffolds with highly controlled pore size, shape and overall porosity from a broad range of relevant materials. metamaterials, regenerative medicine, 3D cell cultures, 3D printing, life science, and cellular agriculture Type: | 2 | 2 | 0 | 8 |
 | clock.bio Extending and improving the quality of life by reversing the harmful effects of time in our cells Ageing is natural but not inevitable. Some cells never age. Imagine if we could decode their rejuvenation programme. Imagine if we could prevent the diseases caused by ageing cells. Imagine a future where health is our default state Type: | 0 | 0 | 0 | 11 |
 | 4Tissue Shaping the future of regenerative medicine 4Tissue is an innovation-led research and clinical development organization. Our mission is to redefine the boundaries of tissue reconstruction, regeneration, and anti-aging, utilizing innovative biocompatible and bioresorbable polymers platform The first product, a bioresorbable injectable hydrogel, is focused on a better cell survival and the full regeneration of adipose tissue for breast reconstruction and augmentation applications. Type: | 1 | 0 | 1 | 6 |
 | Purespring Therapeutics We are Purespring. We are on a mission to radically transform the treatment of kidney diseases. Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases. biotechnology, gene therapy, and kidney diseases Type: | 1 | 1 | 1 | 52 |
 | MicroLub Transformational protein technology for fat replacement, texture enhancement and nutrient delivery in the next generation of alt protein and reduced-fat foods. research and development, food science, fat-reduction, texture enhancement, nutrient delivery, plant-based protein, and sustainability Type: | 2 | 1 | 0 | 4 |
 | Booster Therapeutics Pioneering proteasome therapeutics for a new approach to complex disease Booster Therapeutics is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function. Type: | 0 | 0 | 0 | 7 |
Startup